Atara Biotherapeutics, Inc. (NASDAQ:ATRA) belongs to Healthcare sector. Its weekly performance is 19.05%. On last trading day company shares ended up $54.17. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) distance from 50-day simple moving average (SMA50) is 21.56%. Atara Biotherapeutics, Inc. (NASDAQ:ATRA) announced Thursday, the pricing of its underwritten public offering of 3,461,538 shares of its common stock at a public offering price of $52.00 per share. In addition, Atara Bio granted the underwriters a 30-day option to purchase up to an additional 519,230 shares of common stock at the public offering price.
JD.com, Inc. (NASDAQ:JD) shares decreased -1.16% in last trading session and ended the day at $32.40. JD Gross Margin is 12.10% and its return on assets is -12.60%. JD.com, Inc. (NASDAQ:JD) quarterly performance is -2.50%. Zacks upgraded shares of JD.Com (NASDAQ:JD) from a sell rating to a hold rating in a research report released on Wednesday morning, MarketBeat Ratings reports.
On 10 July, DigitalGlobe, Inc. (NYSE:DGI) shares decreased -0.53% and was closed at $26.09. DGI EPS growth in last 5 year was -29.90%. DigitalGlobe, Inc. (NYSE:DGI) year to date (YTD) performance is -15.76%. ON 22 June, The National Geospatial-Intelligence Agency and DigitalGlobe (NYSE:DGI) have partnered to release an open source software toolkit designed to harness the power of crowdsourced mapping for Geospatial Big Data Analytics. The open source project Hootenanny provides a scalable processing engine and interactive editing interface to enable rapid conflation of map features generated from satellite imagery, UAVs, and mobile devices.
Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) ended the last trading day at $12.41. Company weekly volatility is calculated as 4.74% and price to cash ratio as 3.86. Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA) showed a weekly performance of -1.74%. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) presented positive results from the long-term maintenance REPRIEVE (Relapse prevention study in patients with schizophrenia) clinical study at the 2015 American Society of Clinical Pharmacology (ASCP) Annual Meeting in Miami Beach, Florida.
Mosaic Co (NYSE:MOS) shares increased 0.74% in last trading session and ended the day at $45.04. MOS Gross Margin is 21.00% and its return on assets is 7.20%. Mosaic Co (NYSE:MOS) quarterly performance is -1.17%. On 23 June, The Mosaic Company (NYSE:MOS) released its 2014 Sustainability Report titled, “Leading with Purpose,” which outlines the company’s sustainability progress and new 2020 sustainability targets. The company’s sixth Sustainability Report discloses information on 95 Global Reporting Initiative (GRI) indicators and is prepared in alignment with G4 Core Sustainability Reporting Guidelines, which have an increased focus on materiality.